US markets end considerably higher on upbeat coronavirus treatment news

11 Jul 2020 Evaluate

The US markets ended considerably higher on Friday after Gilead Sciences (GILD) said remdesivir showed a sharp mortality risk drop when used to treat patients suffering of coronavirus. BioNTech's CEO also said the German biotechnology company's coronavirus vaccine candidate could be ready for approval by December. The upbeat treatment and vaccine news overshadowed the reports that the US saw a record number of new infections of COVID-19, rising by more than 63,000 to mark another single-day record, as hospitals in Texas, California and other states also saw rising hospitalizations from the illness. Total US cases of coronavirus climbed to more than 3.1 million and the death toll topped 133,000, according to data compiled by Johns Hopkins University.

Separately, China said that it would impose reciprocal sanctions against US officials after the US imposed sanctions on individuals and institutions for human rights abuses of Uighurs, a mostly Muslim ethnic minority living in China’s Xinjiang province. In economic data, the wholesale cost of US goods and services fell by 0.2% in June, reflecting depressed demand in retail and other major parts of the economy caused by the coronavirus pandemic. Looking forward, investors are bracing for corporate earnings reports, which will kick off in earnest next week, with the banking sector slated to deliver quarterly results that are likely to be disappointing.

Dow Jones Industrial Average jumped 369.21 points or 1.44 percent to 26,075.3, Nasdaq gained 69.69 points or 0.66 percent 10,617.44 and S&P 500 was up by 32.99 points or 1.05 percent to 3,185.04. 

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×